Gijsbert Veerman

1.2k total citations
16 papers, 1.1k citations indexed

About

Gijsbert Veerman is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Gijsbert Veerman has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Gijsbert Veerman's work include Cancer therapeutics and mechanisms (6 papers), DNA Repair Mechanisms (5 papers) and Biochemical and Molecular Research (5 papers). Gijsbert Veerman is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), DNA Repair Mechanisms (5 papers) and Biochemical and Molecular Research (5 papers). Gijsbert Veerman collaborates with scholars based in Netherlands, Sweden and United States. Gijsbert Veerman's co-authors include Godefridus J. Peters, Veronique W.T. Ruiz van Haperen, Jan B. Vermorken, Herbert M. Pinedo, Epie Boven, Paul Noordhuis, Andries M. Bergman, Kees Smid, Boudewijn J.M. Braakhuis and Isabelle Hubeek and has published in prestigious journals such as Cancer Research, Biochemical Pharmacology and European Journal of Cancer.

In The Last Decade

Gijsbert Veerman

16 papers receiving 1.0k citations

Peers

Countries citing papers authored by Gijsbert Veerman

Since Specialization

Citations

This map shows the geographic impact of Gijsbert Veerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gijsbert Veerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gijsbert Veerman more than expected).

Fields of papers citing papers by Gijsbert Veerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gijsbert Veerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gijsbert Veerman. The network helps show where Gijsbert Veerman may publish in the future.

Co-authorship network of co-authors of Gijsbert Veerman

This figure shows the co-authorship network connecting the top 25 collaborators of Gijsbert Veerman. A scholar is included among the top collaborators of Gijsbert Veerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gijsbert Veerman. Gijsbert Veerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Inhibition of thymidylate synthase by 2′,2′-difluoro-2′-deoxycytidine (Gemcitabine) and its metabolite 2′,2′-difluoro-2′-deoxyuridine 2015 ·The International Journal of Biochemistry & Cell Biology ·Richard J. Honeywell, Veronique W.T. Ruiz van Haperen, Gijsbert Veerman, Kees Smid, Godefridus J. Peters	41
2	In vivo Induction of Resistance to Gemcitabine Results in Increased Expression of Ribonucleotide Reductase Subunit M1 as the Major Determinant 2005 ·Cancer Research ·Andries M. Bergman, Paul P. Eijk, Veronique W.T. Ruiz van Haperen, Kees Smid, Gijsbert Veerman, Isabelle Hubeek, Paul van den IJssel, Bauke Ylstra, Godefridus J. Peters	159
3	Collateral sensitivity to gemcitabine (2′,2′-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines11Abbreviations: ara-C,1-β-d-arabinofuranosylcytosine; dCDA, deoxycytidinedeaminase; dCK, deoxycytidine kinase; dCyd, deoxycytidine; dFdC,2′,2′-difluorodeoxycytidine; MDR, multidrug resistance; MRP,multidrug resistance-associated protein; P-gP, P-glycoprotein; SCLC,small cell lung carcinoma; TCA, trichloroacetic acid; TK, thymidinekinase; and VM-26, teniposide, epipodophyllotoxin 4′-demethyl-O-(4,6-O-2-thenylidene-β-d-glucopyranoside). 2001 ·Biochemical Pharmacology ·Andries M. Bergman, Birgitte Munch‐Petersen, Peter Buhl Jensen, Maxwell Sehested, Gijsbert Veerman, Daphne Voorn, Kees Smid, Herbert M. Pinedo, Godefridus J. Peters	24
4	Decreased resistance to gemcitabine (2′,2′-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase 1999 ·Biochemical Pharmacology ·Andries M. Bergman, Herbert M. Pinedo, A.P.M. Jongsma, (unknown), Veronique W.T. Ruiz van Haperen, Gijsbert Veerman, A. Leyva, (unknown), Godefridus J. Peters	67
5	Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines 1999 ·Biochemical Pharmacology ·C.J.A. van Moorsel, Herbert M. Pinedo, Gijsbert Veerman, (unknown), Kees Smid, Willem J.P Loves, Jan B. Vermorken, Pieter E. Postmus, Godefridus J. Peters	34
6	Cross-Resistance of the Gemcitabine Resistant Human Ovarian Cancer Cell Line AG6000 to Standard and Investigational Drugs 1998 ·Advances in experimental medicine and biology ·Andries M. Bergman, Herbert M. Pinedo, Veronique W.T. Ruiz van Haperen, Gijsbert Veerman, Catharina M. Kuiper, Godefridus J. Peters	4
7	Increased Sensitivity to Gemcitabine of P-gP and MRP Overexpressing Human Non-Small Cell Lung Cancer Cell Lines 1998 ·Advances in experimental medicine and biology ·Andries M. Bergman, Herbert M. Pinedo, Gijsbert Veerman, Catharina M. Kuiper, Godefridus J. Peters	10
8	Antitumor activity of prolonged as compared with bolus administration of 2′,2′-difluorodeoxycytidine in vivo against murine colon tumors 1996 ·Cancer Chemotherapy and Pharmacology ·Gijsbert Veerman, Veronique W.T. Ruiz van Haperen, Jan B. Vermorken, Paul Noordhuis, Boudewijn J.M. Braakhuis, Herbert M. Pinedo, Godefridus J. Peters	89
9	Regulation of phosphorylation of deoxycytidine and 2′,2′-difluorodeoxycytidine (gemcitabine); effects of cytidine 5′-triphosphate and uridine 5′-triphosphate in relation to chemosensitivity for 2′,2′-difluorodeoxycytidine 1996 ·Biochemical Pharmacology ·Veronique W.T. Ruiz van Haperen, Gijsbert Veerman, Jan B. Vermorken, Herbert M. Pinedo, Godefridus J. Peters	63
10	Synergistic Interaction between Cisplatin and Gemcitabine in Ovarian and Colon Cancer Cell Lines 1995 ·Advances in experimental medicine and biology ·Andries M. Bergman, Veronique W.T. Ruiz van Haperen, Gijsbert Veerman, Catharina M. Kuiper, Godefridus J. Peters	15
11	Three-Dimensional Cell Cultures as a Model System to Evaluate the Biological Activity of Gemcitabine (2', 2'-Difluoro-2'deoxycytidine) 1995 ·Nucleosides Nucleotides & Nucleic Acids ·Godefridus J. Peters, Evelien Smitskamp-Wilms, Gijsbert Veerman, (unknown), Veronique W.T. Ruiz van Haperen, Herbert M. Pinedo	3
12	Schedule dependence of sensitivity to 2′,2′-difluorodeoxycytidine (gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours 1994 ·Biochemical Pharmacology ·Veronique W.T. Ruiz van Haperen, Gijsbert Veerman, Epie Boven, Paul Noordhuis, Jan B. Vermorken, Godefridus J. Peters	114
13	Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780. 1994 ·PubMed ·Veronique W.T. Ruiz van Haperen, Gijsbert Veerman, S. Eriksson, Epie Boven, Alexander P.A. Stegmann, Mario Hermsen, Jan B. Vermorken, Herbert M. Pinedo, Godefridus J. Peters	151
14	2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines 1993 ·Biochemical Pharmacology ·Veronique W.T. Ruiz van Haperen, Gijsbert Veerman, Jan B. Vermorken, Godefridus J. Peters	213
15	Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts 1993 ·European Journal of Cancer ·Veronique W.T. Ruiz van Haperen, Gijsbert Veerman, Boudewijn J.M. Braakhuis, Jan B. Vermorken, Epie Boven, A. Leyva, Godefridus J. Peters	52
16	Concentration and Time Dependent Growth Inhibition and Metabolism in vitro by 2’,2’-Difluoro-Deoxycytidine (Gemcitabine) 1991 ·Advances in experimental medicine and biology ·Veronique W.T. Ruiz van Haperen, Gijsbert Veerman, Paul Noordhuis, Jan B. Vermorken, Godefridus J. Peters	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact